Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2025-12-25 @ 7:34 PM
Study NCT ID:
NCT00319332
Status:
WITHDRAWN
Last Update Posted:
2015-04-17
First Post:
2006-04-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-09
Start Date Type:
None
Primary Completion Date:
2021-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-02
Completion Date Type:
ESTIMATED
First Submit Date:
2006-04-26
First Submit QC Date:
None
Study First Post Date:
2006-04-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-04-15
Last Update Post Date:
2015-04-17
Last Update Post Date Type:
ESTIMATED